Skip to Content

MP 66 (Quinidine gluconate extended release 324 mg)

Pill imprint MP 66 has been identified as Quinidine gluconate extended release 324 mg.

Quinidine is used in the treatment of arrhythmia; malaria and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Quinidine 324 mg is not a controlled substance under the Controlled Substance Act (CSA).

Quinidine gluconate extended release 324 mg MP 66
Quinidine gluconate extended release 324 mg MP 66  Front
Quinidine gluconate extended release 324 mg MP 66  Back
Quinidine gluconate extended release 324 mg MP 66
Quinidine gluconate extended release 324 mg MP 66
Quinidine gluconate extended release
Imprint:
MP 66
Strength:
324 mg
Color:
White
Size:
11.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Sun Pharmaceutical Industries Inc.
National Drug Code (NDC):
53489-0141
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0027 UDL Laboratories Inc

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide